BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15077192)

  • 1. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins.
    Knockaert M; Blondel M; Bach S; Leost M; Elbi C; Hager GL; Nagy SR; Han D; Denison M; Ffrench M; Ryan XP; Magiatis P; Polychronopoulos P; Greengard P; Skaltsounis L; Meijer L
    Oncogene; 2004 May; 23(25):4400-12. PubMed ID: 15077192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
    Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
    Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
    J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the aryl hydrocarbon receptor (AhR) signalling in liver progenitor cells.
    Procházková J; Kozubík A; Machala M; Vondráček J
    Toxicology; 2011 Jan; 279(1-3):146-54. PubMed ID: 20951181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
    Damiens E; Baratte B; Marie D; Eisenbrand G; Meijer L
    Oncogene; 2001 Jun; 20(29):3786-97. PubMed ID: 11439342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.
    Polychronopoulos P; Magiatis P; Skaltsounis AL; Myrianthopoulos V; Mikros E; Tarricone A; Musacchio A; Roe SM; Pearl L; Leost M; Greengard P; Meijer L
    J Med Chem; 2004 Feb; 47(4):935-46. PubMed ID: 14761195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclin-dependent kinase 4.
    Barhoover MA; Hall JM; Greenlee WF; Thomas RS
    Mol Pharmacol; 2010 Feb; 77(2):195-201. PubMed ID: 19917880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor.
    Reiners JJ; Clift R; Mathieu P
    Carcinogenesis; 1999 Aug; 20(8):1561-6. PubMed ID: 10426807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the growth factor signal transduction pathways and modulators of the cell cycle in endocervical cells from macaques exposed to TCDD.
    Enan E; El-Sabeawy F; Scott M; Overstreet J; Lasley B
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):283-93. PubMed ID: 9707505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways.
    Oesch-Bartlomowicz B; Huelster A; Wiss O; Antoniou-Lipfert P; Dietrich C; Arand M; Weiss C; Bockamp E; Oesch F
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9218-23. PubMed ID: 15972329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E; Barbarino M; Bruzzese F; De Lorenzo S; Caraglia M; Abbruzzese A; Avallone A; Comella P; Caponigro F; Pepe S; Budillon A
    J Cell Physiol; 2003 Apr; 195(1):139-50. PubMed ID: 12599217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle.
    Ge NL; Elferink CJ
    J Biol Chem; 1998 Aug; 273(35):22708-13. PubMed ID: 9712901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained aryl hydrocarbon receptor activity attenuates liver regeneration.
    Mitchell KA; Lockhart CA; Huang G; Elferink CJ
    Mol Pharmacol; 2006 Jul; 70(1):163-70. PubMed ID: 16636136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha modulates effects of aryl hydrocarbon receptor ligands on cell proliferation and expression of cytochrome P450 enzymes in rat liver "stem-like" cells.
    Umannová L; Zatloukalová J; Machala M; Krcmár P; Májková Z; Hennig B; Kozubík A; Vondrácek J
    Toxicol Sci; 2007 Sep; 99(1):79-89. PubMed ID: 17557910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of eugenol and isoeugenol on AhR translocation, target gene expression, and proliferation in human HaCaT keratinocytes.
    Kalmes M; Blömeke B
    J Toxicol Environ Health A; 2012; 75(8-10):478-91. PubMed ID: 22686307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.
    Abdelrahim M; Smith R; Safe S
    Mol Pharmacol; 2003 Jun; 63(6):1373-81. PubMed ID: 12761348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits cell proliferation through arylhydrocarbon receptor-mediated G1 arrest in SK-N-SH human neuronal cells.
    Jin DQ; Jung JW; Lee YS; Kim JA
    Neurosci Lett; 2004 Jun; 363(1):69-72. PubMed ID: 15157999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.